Dysport 300 IU / 500 IU (AbobotulinumtoxinA) by Ipsen.
Indications: Temporary improvement of moderate to severe glabellar lines and lateral canthal lines in adults; therapeutic use in cervical dystonia, blepharospasm, hemifacial spasm, upper/lower limb spasticity and axillary hyperhidrosis (per local SmPC).
Administration: Intramuscular injection by a trained practitioner. Typical glabellar dose: 50 Speywood units divided across 5 injection sites. Speywood units are specific to Dysport and are not interchangeable with other toxins.
Storage: Store unopened vials refrigerated at 2–8 °C. Do not freeze. Use reconstituted product promptly (within 24 h refrigerated).
Prescription-only medicine (POM). Supplied to licensed healthcare professionals only.
| Manufacturer | Ipsen / Galderma |
| Active ingredient | AbobotulinumtoxinA (Clostridium botulinum type A toxin-haemagglutinin complex) 300 or 500 Speywood units; excipients: human albumin, lactose monohydrate. |
| Strength & pack | 1 vial of 300 U or 500 U, lyophilised powder. Pack carries the 2D DataMatrix ("square") serialisation code for authenticity verification. |
| Form | Powder for solution for injection, reconstitute with sterile 0.9% sodium chloride |
| Storage | Store unopened vials refrigerated at 2–8 °C. Do not freeze. Use reconstituted product promptly (within 24 h refrigerated). |
| Regulatory status | Prescription-only medicine (POM). Supplied to licensed healthcare professionals only. |